REGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 765.31 USD -2.88%

Market Cap: $80.2B

	Regeneron Pharmaceuticals Inc NASDAQ:REGN	US
	SPAR Group Ltd OTC:SGPPY	ZA
	LVMH Moet Hennessy Louis Vuitton SE MIL:1MC	FR
S	System1 Group PLC F:BBA	UK

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Healthy Operating Margin

28%

Sustainable 3Y Average Operating Margin

30%

Declining Operating Margin

36% > 28%

Healthy Net Margin

28%

Strong 3Y Average Net Margin

31%

Declining Net Margin

34% > 28%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

26%

Declining Free Cash Flow Margin

24% > 23%

Positive ROE

14%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

Declining ROIC

21% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.